ARKG - BMO ARK Genomic Revolution Fund ETF Series (CAD) (CA05602W1005)

The BMO ARK Genomic Revolution Fund ETF is an actively managed ETF that seeks long-term capital appreciation providing investors exposure to a portfolio managed by ARK Investment Management LLC and comprised primarily of global companies focused on extending and enhancing the quality of human and other life by incorporating technological and scientific developments and advancements in genomics

The BMO ARK Genomic Revolution Fund ETF Series (CAD) is a(n) Equity Exchange Traded Funds (ETF) seeks to invest in Biotech sector located in Global. The BMO Global Asset Management fund’s base currency is CAD and the share class was registered 14.11.2022 with unique ISIN - CA05602W1005. Main exchange is Cboe Canada and ticker symbol is ARKG. The total expense ratio is 0.85%. The BMO ARK Genomic Revolution Fund ETF Series (CAD) pays dividends 1 time(s) per year.